723 related articles for article (PubMed ID: 18772026)
1. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
[TBL] [Abstract][Full Text] [Related]
2. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
Monti JM; Jantos H
Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
[TBL] [Abstract][Full Text] [Related]
3. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
4. Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression.
Berg KA; Harvey JA; Spampinato U; Clarke WP
Prog Brain Res; 2008; 172():287-305. PubMed ID: 18772038
[TBL] [Abstract][Full Text] [Related]
5. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
Meltzer HY; Huang M
Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
[TBL] [Abstract][Full Text] [Related]
6. Serotonin-dopamine interaction: an overview.
Esposito E; Di Matteo V; Di Giovanni G
Prog Brain Res; 2008; 172():3-6. PubMed ID: 18772025
[TBL] [Abstract][Full Text] [Related]
7. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors.
Navailles S; Moison D; Ryczko D; Spampinato U
J Neurochem; 2006 Nov; 99(4):1311-9. PubMed ID: 17018023
[TBL] [Abstract][Full Text] [Related]
8. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
Bubar MJ; Cunningham KA
Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
[TBL] [Abstract][Full Text] [Related]
9. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
[TBL] [Abstract][Full Text] [Related]
10. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study.
Invernizzi RW; Pierucci M; Calcagno E; Di Giovanni G; Di Matteo V; Benigno A; Esposito E
Neuroscience; 2007 Feb; 144(4):1523-35. PubMed ID: 17161544
[TBL] [Abstract][Full Text] [Related]
11. 5-HT receptor regulation of neurotransmitter release.
Fink KB; Göthert M
Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
[TBL] [Abstract][Full Text] [Related]
12. Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study.
Nowak P; Szczerbak G; Biedka I; Drosik M; Kostrzewa RM; Brus R
J Physiol Pharmacol; 2006 Dec; 57(4):583-97. PubMed ID: 17229983
[TBL] [Abstract][Full Text] [Related]
13. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
Kuroki T; Nagao N; Nakahara T
Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
[TBL] [Abstract][Full Text] [Related]
14. Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.
Gobert A; Billiras R; Cistarelli L; Millan MJ
J Neurosci Methods; 2004 Dec; 140(1-2):141-52. PubMed ID: 15589344
[TBL] [Abstract][Full Text] [Related]
15. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
[TBL] [Abstract][Full Text] [Related]
16. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
Fox SH; Chuang R; Brotchie JM
Prog Brain Res; 2008; 172():479-94. PubMed ID: 18772047
[TBL] [Abstract][Full Text] [Related]
18. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems.
Giorgetti M; Tecott LH
Eur J Pharmacol; 2004 Mar; 488(1-3):1-9. PubMed ID: 15044029
[TBL] [Abstract][Full Text] [Related]
19. Serotonin/dopamine interaction in learning.
Olvera-Cortés ME; Anguiano-Rodríguez P; López-Vázquez MA; Alfaro JM
Prog Brain Res; 2008; 172():567-602. PubMed ID: 18772051
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors.
Clinckers R; Smolders I; Meurs A; Ebinger G; Michotte Y
J Neurochem; 2004 May; 89(4):834-43. PubMed ID: 15140183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]